157 related articles for article (PubMed ID: 2890149)
21. Effects of hepatic disease on the pharmacokinetics of famotidine and effects of famotidine on hepatic hemodynamics and peptic ulcer.
Ohnishi K
Hepatogastroenterology; 1990 Jul; 37 Suppl 1():6-10. PubMed ID: 2210613
[TBL] [Abstract][Full Text] [Related]
22. Impaired bioavailability of famotidine given concurrently with a potent antacid.
Barzaghi N; Gatti G; Crema F; Perucca E
J Clin Pharmacol; 1989 Jul; 29(7):670-2. PubMed ID: 2569486
[TBL] [Abstract][Full Text] [Related]
23. Buccal delivery of an alpha 2-adrenergic receptor antagonist, atipamezole, in humans.
Huupponen R; Karhuvaara S; Anttila M; Vuorilehto L; Scheinin H
Clin Pharmacol Ther; 1995 Nov; 58(5):506-11. PubMed ID: 7586944
[TBL] [Abstract][Full Text] [Related]
24. Comparison of hemostatic effects by route of H2 receptor antagonist administration following endoscopic mucosal resection in patients with neoplastic gastric lesions.
Satoh K; Yamamoto H; Kawata H; Osawa H; Hanatsuka K; Kita H; Sunada K; Hirasawa T; Yoshizawa M; Ajibe H; Satoh Y; Sunada F; Sugano K
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():105-10. PubMed ID: 15943856
[TBL] [Abstract][Full Text] [Related]
25. Ranitidine disposition in severe hepatic cirrhosis.
Gonzalez-Martin G; Paulos C; Veloso B; Chesta J; Novoa X; Arancibia A
Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):139-42. PubMed ID: 3557740
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of famotidine in elderly patients with and without renal insufficiency and in healthy young volunteers.
Inotsume N; Nishimura M; Fujiyama S; Sagara K; Sato T; Imai Y; Matsui H; Nakano M
Eur J Clin Pharmacol; 1989; 36(5):517-20. PubMed ID: 2568929
[TBL] [Abstract][Full Text] [Related]
27. Safety and pharmacokinetics of single oral and intravenous doses of fluconazole in healthy subjects.
Shiba K; Saito A; Miyahara T
Clin Ther; 1990; 12(3):206-15. PubMed ID: 2379224
[TBL] [Abstract][Full Text] [Related]
28. HPLC reveals famotidine in the urine up to five days after a single 20 mg oral dose.
Bologna M; Napolitano T; Biordi L; Carlucci G
Drugs Exp Clin Res; 1988; 14(6):419-21. PubMed ID: 2905638
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of picumast dihydrochloride in patients with liver cirrhosis.
Neugebauer G; Raedsch R; Stiehl A; Kaufmann B; Besenfelder E; Neubert P; Walter-Sack I
Arzneimittelforschung; 1989 Oct; 39(10A):1343-7. PubMed ID: 2576360
[TBL] [Abstract][Full Text] [Related]
30. Colchicine clearance is impaired in alcoholic cirrhosis.
Leighton JA; Bay MK; Maldonado AL; Schenker S; Speeg KV
Hepatology; 1991 Dec; 14(6):1013-5. PubMed ID: 1959847
[TBL] [Abstract][Full Text] [Related]
31. Effect of oral famotidine on 24-hour intragastric acidity.
Santana IA; Lanzon-Miller S; Pounder RE
Postgrad Med J; 1986; 62 Suppl 2():39-42. PubMed ID: 2890150
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of famotidine in patients with cirrhosis and ascites.
Vinçon G; Baldit C; Couzigou P; Demotes-Mainard F; Elouaer-Blanc L; Bannwarth B; Begaud B
Eur J Clin Pharmacol; 1992; 43(5):559-62. PubMed ID: 1483496
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of CM 57755, a new histamine H2-receptor antagonist, after single oral doses in man.
Necciari J; Mery D; Garriot P; Escourrou J; Cautreels W
Int J Clin Pharmacol Res; 1985; 5(6):457-65. PubMed ID: 2869002
[TBL] [Abstract][Full Text] [Related]
34. Plasma famotidine concentration versus intragastric pH in patients with upper gastrointestinal bleeding and in healthy subjects.
Echizen H; Shoda R; Umeda N; Ishizaki T
Clin Pharmacol Ther; 1988 Dec; 44(6):690-8. PubMed ID: 2904311
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of famotidine in patients with cystic fibrosis.
Maish WA; McCubbin MM; Letzig LG; Farrar HC; Kearns GL
J Clin Pharmacol; 1998 Nov; 38(11):1010-6. PubMed ID: 9824781
[TBL] [Abstract][Full Text] [Related]
36. Temazepam clearance unaltered in cirrhosis.
Ochs HR; Greenblatt DJ; Verburg-Ochs B; Matlis R
Am J Gastroenterol; 1986 Jan; 81(1):80-4. PubMed ID: 2867675
[TBL] [Abstract][Full Text] [Related]
37. Effect of oral and intramuscular famotidine on pH and volume of gastric contents.
Abe K; Shibata M; Demizu A; Hazano S; Sumikawa K; Enomoto H; Mashimo T; Tashiro C; Yoshiya I
Anesth Analg; 1989 Apr; 68(4):541-4. PubMed ID: 2564752
[No Abstract] [Full Text] [Related]
38. [Comparative studies on hemodynamic effects of intravenous cimetidine, ranitidine and famotidine in intensive care unit patients].
Omote K; Namiki A; Sumita S; Takahashi T; Ujike Y; Hagiwara T
Masui; 1987 Jun; 36(6):940-7. PubMed ID: 2888909
[No Abstract] [Full Text] [Related]
39. Comparison of effects of oral and intravenous famotidine on inhibition of nocturnal gastric acid secretion.
Ryan JR; Vargas R; McMahon FG; Chremos AN
Am J Med; 1986 Oct; 81(4B):60-4. PubMed ID: 2877576
[TBL] [Abstract][Full Text] [Related]
40. Interaction of diazepam with famotidine and cimetidine, two H2-receptor antagonists.
Locniskar A; Greenblatt DJ; Harmatz JS; Zinny MA; Shader RI
J Clin Pharmacol; 1986 Apr; 26(4):299-303. PubMed ID: 2871051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
